Congenital Adrenal Hyperplasia: Adolescence and Transition

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background: For individuals with congenital adrenal hyperplasia (CAH), transition is synonymous with the time when the young adult shifts from the paediatric clinic to adult services and assumes primary responsibility for managing the condition, and medical issues change from a focus on growth and development to long-term health preservation.Sex and fertility issues become a focus. The complexities of CAH in teenage life demand that the clinical management team provide subjects with special attention during the transition from paediatric to adult care. Educating subjects on the principles of adrenal suppression and the diurnal rhythm of the adrenal glands requires time and encouragement in the first few visits to adult clinics. Conclusions: The transition period affords the young adult an opportunity for an educational review of CAH that may never arise again so conveniently and will be beneficial for optimising their well-being as adults.

Related collections

Author and article information

Journal

Journal ID (publisher-id): HRE

Journal ID (nlm-ta): Horm Res Paediatr

Journal ID (doi): 10.1159/issn.1663-2818

Title: Hormone Research in Paediatrics

Publisher: S. Karger AG

ISBN: 978-3-8055-8475-3

ISBN: 978-3-8055-8476-0

ISSN (Print): 1663-2818

ISSN (Electronic): 1663-2826

Publication date Subscription-year: 2007

Publication date (Print): December 2007

Publication date (Electronic): 10 December 2007

Volume: 68

Issue: Suppl 5

Pages: 155-157

Affiliations

Department of Endocrinology, University College London Hospitals, London, UK

Article

Publisher ID: 110614 Other ID: Horm Res 2007;68:155–157

DOI: 10.1159/000110614

PubMed ID: 18174736

SO-VID: 8058b235-e2ce-4a88-b9aa-1b56f8b6831b

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Page count

Pages: 3

Comments

Comment on this article

scite_

Cited by 5

See all cited by

- Version 1

Call for Papers: Epidemiology and Health Impacts of Neuroendocrine Tumors

Submit here before August 30, 2024